Market Research Life Sciences Market Research Pharmaceuticals Market Research Diseases & Conditions Market Research COVID-19/Coronavirus Market Research

Huntington Disease Treatment Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis

Best Price Guarantee Length Publisher Published Date SKU
from $2,490 130 Pages Renub Research April, 2022 RNBR17135996
Best Price Guarantee
Price from $2,490
Length 130 Pages
Publisher Renub Research
Published Date April, 2022
SKU RNBR17135996

Huntington Disease Treatment Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis

Global Huntington's disease Treatment Market will reach US$ 1,458.83 Million by 2027. Huntington's Disease (HD) is a hereditary neurodegenerative disease driven by an expansion of a repeating CAG triplet series in the huntingtin gene (HTT) on chromosome 4, which results in a protein with an abnormally long polyglutamine sequence. Moreover, HD is one of a more prominent family of polyglutamine repeat diseases, all of which are neurodegenerative diseases. It is inherited in an autosomal dominant fashion so that each child of an affected parent has a 50% chance of developing the disorder.

Trends Shaping the Global Huntington's Disease Treatment Market Size:

Globally, the rising prevalence of rare genetic disorders amongst the metropolitan population has grown the incidence of Huntington's disease, with key healthcare stakeholders like Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, and others attempting to discover novel medicinal approaches, providing a platform for manufacturers to expand their influence in the global market.

However, due to the global COVID-19, the Huntington's disease treatment market's growth rate slowed from 2019-2020. Online pharmacies' distribution channel was selling off-label drugs to manage HD symptoms during the pandemic, such as antidepressants, antipsychotics, and anticonvulsants. As a result of the government-imposed lockdown, clinical trials were postponed during the COVID-19 pandemic.

Besides, the market is anticipated to grow between 2022 and 2023. As of 2021, most hospitals and clinics globally reported increased clinical visits for HD treatment. Ingrezza's has developed its label to include chorea associated with Huntington's disorder. Owning to the increased incidence of HD in western countries. These are expected to be significant market drivers.As per our analysis, Global Huntington's Disease Treatment Market Size is Expanding at a CAGR of 23.81% During 2021-2027.

Global Huntington's disease Treatment Industry was US$ 405.03 Million in 2021:

Based on Treatment Type, the symptomatic treatment segment holds the significant market share. This growth is because of the availability of symptom management products and patent protection for these products. Xenazine and Austedo are assessed as first-line therapy for chorea linked with Huntington's disease. The R&D of potential product candidates for symptom management of Huntington's disease may contribute to segment growth. In October 2021, the U.S. FDA approved orphan drug designation for SOM BIOTECH's drug SOM3355 to treat chorea associated with Huntington's condition. As a result, the product has exclusivity for 7 years upon U.S. FDA approval.

Geographically, North America holds the dominant market in the Huntington's disease treatment market:

In North America, there is a massive demand for Huntington's disease treatment due to the increased burden of the disease, technological advancements, increased healthcare expenditure, proactive government initiatives, and raised patient awareness about treatment products for Huntington's disease.

Similarly, in the Asia Pacific, Huntington's disease treatment market is anticipated to witness significant growth over the coming year due to untapped potential, increased product penetration, and the growing preponderance of the disease in emerging countries over the forecast period. An increasing number of initiatives being undertaken by governments to improve the population's health status is anticipated to drive the growth of the HD treatment market in the region.

Key Players and Market Share Insights:

Key players like Pfizer Inc, Bausch Health Cos, Dr. Reddy's Laboratories, H Lundbeck, Hikma Pharmaceuticals Plc, Sun Pharmaceutical Industries Limited, Lupin Ltd., and Alnylam Pharmaceuticals are contributing to market development by adopting various strategies like new product launches and partnerships to gain higher market revenue.

Renub Research report titled “Global Huntington’s Disease Treatment Market by Treatment Type (Symptomatic Therapy and Disease-modifying Therapy), Drug Type (Antidopaminergic, Anticonvulsants, Antipsychotics, Antidepressants), End-User (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Company Analysis (Pfizer Inc, Bausch Health Cos, Dr Reddy's Laboratories, H Lundbeck, Hikma Pharmaceuticals Plc, Sun Pharmaceutical Industries Limited, Lupin Ltd. and Alnylam Pharmaceuticals)” provides a complete analysis of Global Huntington’s Disease Treatment Industry.

Treatment Type – the Market has been covered from 2 viewpoints:

1. Symptomatic Therapy
2. Disease-modifying Therapy

Drug Type – the Markethas been covered from 4 viewpoints:

1. Antidopaminergic
2. Anticonvulsants
3. Antipsychotics
4. Antidepressants

End User – the Market has been covered from 4 viewpoints:

1. Hospital Pharmacies
2. Specialty Pharmacies
3. Retail Pharmacies
4. Others

Region – the Market has been covered from 5 viewpoints:

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa

Company Insights:

• Overview
• Recent Development
• Revenue

Company Analysis:

1. Pfizer Inc
2. Bausch Health Cos
3. Dr Reddy's Laboratories
4. H Lundbeck
5. Hikma Pharmaceuticals Plc
6. Sun Pharmaceutical Industries Limited
7. Lupin Ltd.
8. Alnylam Pharmaceuticals


1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Huntington’s Disease Treatment Market
6. GlobalHuntington’s Disease Treatment Market - Share Analysis
6.1 By Treatment Type
6.2 By Drug Type
6.3 By End User
6.4 By Region
7. Global Huntington’s Disease Treatment Market– By Treatment Type
7.1 Symptomatic Therapy
7.2 Disease-modifying Therapy
8. Global Huntington’s Disease Treatment Market– By Drug Type
8.1 Antidopaminergic
8.2 Anticonvulsants
8.3 Antipsychotics
8.4 Antidepressants
9. Global Huntington’s Disease Treatment Market– By End User
9.1 Hospital Pharmacies
9.2 Specialty Pharmacies
9.3 Retail Pharmacies
9.4 Others
10. Global Huntington’s Disease Treatment Market– By Region
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Latin America
10.5 Middle East & Africa
11. Porters Five Forces
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. Key Players
12.1 Pfizer Inc.
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue
12.2 Bausch Health Cos
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue
12.3 Dr Reddy's Laboratories
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue
12.4 H Lundbeck
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue
12.5 Hikma Pharmaceuticals Plc
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue
12.6 Sun Pharmaceutical Industries Limited
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue
12.7 Lupin Ltd.
12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue
12.8 Alnylam Pharmaceuticals
12.8.1 Overview
12.8.2 Recent Development
12.8.3 Revenue
List of Figures:
Figure-01: Global – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-02: Global – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-03: Treatment Type – Symptomatic Therapy Market (Million US$), 2016 – 2021
Figure-04: Treatment Type – Forecast for Symptomatic Therapy Market (Million US$), 2022 – 2027
Figure-05: Treatment Type – Disease-modifying Therapy Market (Million US$), 2016 – 2021
Figure-06: Treatment Type – Forecast for Disease-modifying Therapy Market (Million US$), 2022 – 2027
Figure-07: Drug Type – Antidopaminergic Market (Million US$), 2016 – 2021
Figure-08: Drug Type – Forecast for Antidopaminergic Market (Million US$), 2022 – 2027
Figure-09: Drug Type – Anticonvulsants Market (Million US$), 2016 – 2021
Figure-10: Drug Type – Forecast for Anticonvulsants Market (Million US$), 2022 – 2027
Figure-11: Drug Type – Antipsychotics Market (Million US$), 2016 – 2021
Figure-12: Drug Type – Forecast for Antipsychotics Market (Million US$), 2022 – 2027
Figure-13: Drug Type – Antidepressants Market (Million US$), 2016 – 2021
Figure-14: Drug Type – Forecast for Antidepressants Market (Million US$), 2022 – 2027
Figure-15: End User – Hospital Pharmacies Market (Million US$), 2016 – 2021
Figure-16: End User – Forecast for Hospital Pharmacies Market (Million US$), 2022 – 2027
Figure-17: End User – Specialty Pharmacies Market (Million US$), 2016 – 2021
Figure-18: End User – Forecast for Specialty Pharmacies Market (Million US$), 2022 – 2027
Figure-19: End User – Retail Pharmacies Market (Million US$), 2016 – 2021
Figure-20: End User – Forecast for Retail Pharmacies Market (Million US$), 2022 – 2027
Figure-21: End User – Others Market (Million US$), 2016 – 2021
Figure-22: End User – Forecast for Others Market (Million US$), 2022 – 2027
Figure-23: North America – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-24: North America – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-25: Europe – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-26: Europe – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-27: Asia Pacific – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-28: Asia Pacific – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-29: Latin America – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-30: Latin America – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-31: Middle East & Africa – Huntington’s Disease Treatment Market (Million US$), 2016 – 2021
Figure-32: Middle East & Africa – Forecast for Huntington’s Disease Treatment Market (Million US$), 2022 – 2027
Figure-33: Pfizer Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-34: Pfizer Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-35: Bausch Health Cos – Global Revenue (Million US$), 2016 – 2021
Figure-36: Bausch Health Cos – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-37: Dr Reddy's Laboratories – Global Revenue (Million US$), 2016 – 2021
Figure-38: Dr Reddy's Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-39: H Lundbeck – Global Revenue (Million US$), 2016 – 2021
Figure-40: H Lundbeck – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-41: Hikma Pharmaceuticals Plc – Global Revenue (Million US$), 2016 – 2021
Figure-42: Hikma Pharmaceuticals Plc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: Sun Pharmaceutical Industries Limited – Global Revenue (Million US$), 2016 – 2021
Figure-44: Sun Pharmaceutical Industries Limited – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-45: Lupin Ltd. – Global Revenue (Million US$), 2016 – 2021
Figure-46: Lupin Ltd. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-47: Alnylam Pharmaceuticals – Global Revenue (Million US$), 2016 – 2021
Figure-48: Alnylam Pharmaceuticals – Forecast for Global Revenue (Million US$), 2022 – 2027
List of Tables:
Table-01: Global – Huntington’s Disease Treatment Market Share by Treatment Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Huntington’s Disease Treatment Market Share by Treatment Type (Percent), 2022 – 2027
Table-03: Global – Huntington’s Disease Treatment Market Share by Drug Type (Percent), 2016 – 2021
Table-04: Global – Forecast for Huntington’s Disease Treatment Market Share by Drug Type (Percent), 2022 – 2027
Table-05: Global – Huntington’s Disease Treatment Market Share by End-User (Percent), 2016 – 2021
Table-06: Global – Forecast for Huntington’s Disease Treatment Market Share by End-User (Percent), 2022 – 2027
Table-07: Global – Huntington’s Disease Treatment Market Share by Region (Percent), 2016 – 2021
Table-08: Global – Forecast for Huntington’s Disease Treatment Market Share by Region (Percent), 2022 – 2027

$2,490
$3,490

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings